Peptides

Overview

Peptides are short chains of Amino Acids linked by peptide bonds, typically defined as containing between 2 and 50 residues, distinguishing them from larger polypeptides and proteins. As fundamental biological molecules, peptides participate in virtually every physiological process: they function as hormones, neurotransmitters, signaling molecules, antimicrobial agents, and structural components. Their relatively small size compared to full proteins confers key pharmacological advantages, including improved tissue penetration, lower immunogenicity, and the capacity to engage challenging molecular targets such as protein–protein interaction interfaces that are inaccessible to small-molecule drugs. Peptides are biosynthesized through ribosomal translation or non-ribosomal enzymatic pathways, and can also be generated through the hydrolysis of larger proteins by proteases, a process central to both digestion and the production of bioactive food-derived peptides.

From a therapeutic standpoint, peptides occupy a privileged position at the interface of small molecules and biologics. Their modular amino acid sequences can be rationally engineered to confer high specificity for receptor binding, enzyme inhibition, or immune modulation. Advances in solid-phase peptide synthesis, recombinant expression, and, more recently, artificial intelligence-guided design have dramatically expanded the accessible sequence and structural space for therapeutic peptide discovery. These attributes have made peptides central targets and tools across dermatology, oncology, nanomedicine, and food science.

Focus of Latest Publications

Recent literature reflects a broad and rapidly evolving role for peptides across multiple biomedical and applied scientific domains.

In the field of dermatology and longevity medicine, peptides have emerged as a cornerstone of integrative skin rejuvenation strategies. A 2026 review in Dermatology and Therapy examined the validity of a combined "In and Out" approach to skin aging, in which topical formulations—including retinoids, peptides, antioxidants, and exosome-based formulations—are used alongside internal nutraceuticals such as NAD+ precursors, collagen peptides, polyphenols, and microbiome modulators. This paradigm reflects the growing recognition that peptides act both locally, by stimulating collagen synthesis and modulating extracellular matrix turnover, and systemically, through orally administered collagen peptide supplementation that may influence skin hydration and elasticity from within.

In oncology, peptides have gained recognition as next-generation immunotargeting agents. A 2026 study published in Translational Oncology specifically examined their role in gynecological cancers, including ovarian cancer, endometrial cancer, and recurrent cervical cancer, highlighting that peptides are now considered important next-generation substances for immunotargeting. Their ability to bind tumor-associated antigens with high affinity and selectivity positions them as attractive alternatives or complements to antibody-based therapies, particularly in contexts where tumor heterogeneity or immune evasion—including through pathways such as oxidative stress and KEAP1 dysregulation—limits conventional immunotherapy efficacy. Peptides targeting immune checkpoint molecules such as anti-PD-L1 have attracted particular attention; a study published in Cell using the PocketXMol generative framework successfully designed PD-L1-binding peptides, achieving a success rate that substantially exceeded traditional library screening approaches.

Computational and AI-driven peptide design has become one of the most active research frontiers. A 2026 paper in the Journal of Chemical Information and Modeling introducing the High-PepBinder framework explicitly articulated the core challenge: while peptides offer unique advantages in targeting complex protein surfaces, their rational design has historically been constrained by the vastness of the sequence space and the limitations of traditional experimental and computational approaches. By leveraging protein language models (pLMs) and latent diffusion architectures, High-PepBinder enables affinity-aware, target-specific peptide generation. Similarly, a broad review in Bioactive Materials (2026) situated peptide design within the wider context of AI-driven protein engineering and sustainable nanomedicine, arguing that these capabilities support the rational design of proteins and peptides with enhanced specificity, therapeutic efficacy, and safety, while enabling personalized treatment strategies tailored to individual molecular profiles.

Beyond therapeutic applications, peptides also play a functional role in food science and nutrition. Research published in Food Research International (2026) on the decolorization of Antarctic krill hydrolysate for salt reduction in surimi gel demonstrated that processing conditions can be optimized to preserve functional components such as peptides and Amino Acids, even while achieving a decolorization rate exceeding 93%. This underscores the importance of bioactive peptides derived from marine sources as nutritionally and technologically valuable ingredients.

Key Publications

• May Decolorization of Antarctic krill hydrolysate for salt reduction in surimi gel: improvement of taste, gel properties, and flavor profile. (Food research international (Ottawa, Ont.), 2026, PMID 41794503): "It achieved a decolorization rate of 93.31% while effectively preserving functional components such as peptides and amino acids."
• Apr High-PepBinder: A pLM-Guided Latent Diffusion Framework for Affinity-Aware Target-Specific Peptide Design. (Journal of chemical information and modeling, 2026, PMID 41934387): "Peptides, as therapeutic molecules, offer unique advantages in targeting complex protein surfaces, yet their rational design remains limited by the vastness of the sequence space and the constraints of traditional approaches."
• Apr Small but mighty: Peptides as next-generation immunotargeting agents in gynecological cancers. (Translational oncology, 2026, PMID 41930712): "For these reasons, peptides are now considered important next-generation substances for immunotargeting."
• Apr Unified modeling of 3D molecular generation via atomic interactions with PocketXMol. (Cell, 2026, PMID 41713417): "We also adopted PocketXMol to generate PD-L1-binding peptides, resulting in a success rate that largely exceeds library screening."
• Apr Artificial intelligence driven protein design and sustainable nanomedicine for advanced theranostics. (Bioactive materials, 2026, PMID 41674557): "These capabilities support the rational design of proteins and peptides with enhanced specificity, therapeutic efficacy, and safety, while enabling personalized treatment strategies tailored to individual molecular profiles."
• Apr Integrative Dermatology for Longevity: The Synergy of Topical and Internal Approaches. (Dermatology and therapy, 2026, PMID 41926038): "This review examines the validity of an integrative 'In and Out' approach, combining topical treatments, such as retinoids, peptides, antioxidants, and exosome-based formulations, with internal nutraceuticals including NAD+ precursors, collagen peptides, polyphenols, and microbiome modulators."